These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31061163)

  • 21. High-Throughput Screening Assays for Dengue Antiviral Drug Development.
    Jabanathan SG; Xuan LZ; Ramanathan B
    Methods Mol Biol; 2021; 2296():279-302. PubMed ID: 33977455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compounds.
    Bartholomeusz A; Tomlinson E; Wright PJ; Birch C; Locarnini S; Weigold H; Marcuccio S; Holan G
    Antiviral Res; 1994 Aug; 24(4):341-50. PubMed ID: 7993077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
    De Burghgraeve T; Kaptein SJ; Ayala-Nunez NV; Mondotte JA; Pastorino B; Printsevskaya SS; de Lamballerie X; Jacobs M; Preobrazhenskaya M; Gamarnik AV; Smit JM; Neyts J
    PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
    Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology and disease burden of children hospitalized for viral infections within the family Flaviviridae in China: A national cross-sectional study.
    Wang R; Wang X; Zhang L; Feng G; Liu M; Zeng Y; Xie Z
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010562. PubMed ID: 35788743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
    Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
    Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel antiviral activity of baicalein against dengue virus.
    Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
    BMC Complement Altern Med; 2012 Nov; 12():214. PubMed ID: 23140177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten years of dengue drug discovery: progress and prospects.
    Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
    Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
    Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
    PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals.
    Pu S; Schor S; Karim M; Saul S; Robinson M; Kumar S; Prugar LI; Dorosky DE; Brannan J; Dye JM; Einav S
    Antiviral Res; 2020 Dec; 184():104966. PubMed ID: 33137362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a Direct-Acting Antiviral Agent Targeting RNA Helicase via a Graphene Oxide Nanobiosensor.
    Kim J; Park SJ; Park J; Shin H; Jang YS; Woo JS; Min DH
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25715-25726. PubMed ID: 34036784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
    Franco EJ; Pires de Mello CP; Brown AN
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
    Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.
    Smith JL; Stein DA; Shum D; Fischer MA; Radu C; Bhinder B; Djaballah H; Nelson JA; Früh K; Hirsch AJ
    J Virol; 2014 May; 88(10):5533-42. PubMed ID: 24599995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant Activity of Kaempferol Towards Dengue Virus and Japanese Encephalitis Virus.
    Care C; Sornjai W; Jaratsittisin J; Hitakarun A; Wikan N; Triwitayakorn K; Smith DR
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32164193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An adenosine nucleoside inhibitor of dengue virus.
    Yin Z; Chen YL; Schul W; Wang QY; Gu F; Duraiswamy J; Kondreddi RR; Niyomrattanakit P; Lakshminarayana SB; Goh A; Xu HY; Liu W; Liu B; Lim JY; Ng CY; Qing M; Lim CC; Yip A; Wang G; Chan WL; Tan HP; Lin K; Zhang B; Zou G; Bernard KA; Garrett C; Beltz K; Dong M; Weaver M; He H; Pichota A; Dartois V; Keller TH; Shi PY
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20435-9. PubMed ID: 19918064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel inhibitor of dengue virus replication that targets the capsid protein.
    Byrd CM; Dai D; Grosenbach DW; Berhanu A; Jones KF; Cardwell KB; Schneider C; Wineinger KA; Page JM; Harver C; Stavale E; Tyavanagimatt S; Stone MA; Bartenschlager R; Scaturro P; Hruby DE; Jordan R
    Antimicrob Agents Chemother; 2013 Jan; 57(1):15-25. PubMed ID: 23070172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.